Voluntary scheme aggregate net sales and payment information: November 2024
Information on how the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG) is controlling spend on branded medicines in the NHS.
Documents
Details
This document sets out the聽NHS鈥檚 quarterly aggregate net sales and payment information on pharmaceuticals for November 2024 .
罢丑别听2024 voluntary scheme for branded medicines pricing, access and growth听(VPAG)聽is an agreement between the Department for Health and Social Care,聽NHS聽England and the Association of the British Pharmaceutical Industry that aims to:
- promote better patient outcomes and a healthier population
- support UK economic growth
- contribute to a financially sustainable NHS
Updates to this page
-
Amended tables 1A and 1C to reflect updates to the calculation of the baseline for measured sales in respect of the 2024 voluntary scheme, statutory scheme and parallel imports in accordance with Annex 4 of the 2024 voluntary scheme.
-
First published.